Article Sidebar

PDF
Date Published: 30/09/2023
Online Published: 30/09/2023
Abstract Views: 224
Views PDF: 180
DOI: https://doi.org/10.58490/ctump.2023i64.585
Issue
No. 64 (2023)
Section
Article
How to Cite
Le, T. K. D., Nguyen, M. P., q, H. B., Pham, T. H., & Le, T. M. H. (2023). RESEARCH ON ADHERENCE TO PRE-ECLAMPSIA PROPHYLAXIS AND THE EFFECTIVENESS OF EDUCATIONAL INTERVENTIONS ON ADHERENCE KNOWLEDGE OF PREGNANT WOMEN AT CAN THO GYNECOLOGY AND OBSTETRICS HOSPITAL. Cantho Journal of Medicine and Pharmacy, 64, 186-192. https://doi.org/10.58490/ctump.2023i64.585

RESEARCH ON ADHERENCE TO PRE-ECLAMPSIA PROPHYLAXIS AND THE EFFECTIVENESS OF EDUCATIONAL INTERVENTIONS ON ADHERENCE KNOWLEDGE OF PREGNANT WOMEN AT CAN THO GYNECOLOGY AND OBSTETRICS HOSPITAL

Thi Kim Dinh Le1,, Minh Phuong Nguyen2, Hoang Bay q1, Thuy Hong Pham1, Thi My Hanh Le1
1 Can Tho Gynecology and Obstetrics Hospital
2 Can Tho University Medicine and Pharmacy

Main Article Content

Abstract

Background: Improving aspirin adherence in preeclampsia prophylaxis is critical to optimizing treatment outcomes. Objectives: 1/ Determine the adherence rate of pregnant women who come for pre-eclampsia prevention examination and treatment; 2/ Find out a number of factors related to the treatment adherence of pregnant women who come for pre-eclampsia prevention examination and treatment; 3/ Evaluating the results of the intervention, communication and counseling to change the treatment adherence behavior of pregnant women who come for preeclampsia preventive treatment and examination. Materials and methods: A cross-sectional descriptive study and no control group on 33 pregnant women assigned to aspirin prophylaxis for preeclampsia at the Examination Department  of Can Tho Gynecology and Obstetrics  Hospital from May 2022 to August 2022. Data analysis using SPSS 20.0 software. Results: The rate of adherence to general prophylaxis for preeclampsia accounted for 57.6%. The overweight and obese group before pregnancy had a 15.3 times higher compliance rate than the non-obese group; The difference was statistically significant with p=0.002. After the intervention, the rate of knowledge about preeclampsia increased from 12.1% to 93.9% with p<0.001. After the intervention, the percentage of knowledge about preventive treatment increased significantly from 6.1% to 81.8% with p<0.001. Conclusions: Counseling to change treatment adherence knowledge of pregnant women taking aspirin for pre-eclampsia has significant effectiveness.

Article Details

Keywords

preeclampsia, aspirin, hospital

References

1. WHO. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva. 2011.
2. WHO. Antiplatelet agents for preventing pre-eclampsia and complications. WHO. 2007.
3. Cao Ngọc Thành, Trương Quang Huy và Võ Văn Khoa. Đánh giá hiệu quả điều trị dự phòng bệnh lý tiền sản giật - sản giật bằng aspirin ở những thaiphụ có nguy cơ cao. Tạp chí Phụ Sản. 2015. 13(3), tr. 47-53.
4. Vinogradov, R., Boag, C., and et al. Aspirin non-response in pregnant women at increased risk of pre-eclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020. Vol 254, 292–297. https://doi.org/10.1016/j.ejogrb.2020.09.036
5. Wright, D., Poon, L. C., Rolnik, and et al. Aspirin for evidence-based preeclampsia prevention trial: Influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. American Journal of Obstetrics and Gynecology. 2017. 217(6), 685.e1–e5. https://doi.org/10.1016/j.ajog.2017.08.110
6. Van Montfort, P., Scheepers, H. C. J., and et al. Low-dose-aspirin usage among women with an increased preeclampsia risk: A prospective cohort study. Acta Obstetricia et Gynecologica
Scandinavica. 2020. 99 (7), 875–883. https://doi.org/10.1111/aogs.13808
7. Rolnik D.L., Wright D., Poon L.C. et al. Aspirin versus Placebo in Pregnancies at High Risk for
Preterm Preeclampsia. N Engl J Med, 2017. 377(7), pp. 613–622. DOI: 10.1056/NEJMoa1704559
8. Carolien Nienke Heleen Abheiden. Aspirin adherence during high-risk pregnancies, a questionnaire study. Observational Study, 2016. 6(4):350-355. https://doi.org/10.1016/j.preghy.2016.08.232
9. Kate Navaratnam. How important is aspirin adherence when evaluating effectiveness of low-
dose aspirin?. Eur J Obstet Gynecol Reprod Biol. 2017. 219:1-9. https://doi.org/10.1016/j.ejogrb.2017.10.004
10. Raya Vinogradov , Vikki Joanne Smith. Aspirin non-adherence in pregnant women at risk of preeclampsia (ANA): a qualitative study. Health Psychol Behav Med. 2021; 9(1): 681–700. https://doi.org/10.1080/21642850.2021.1951273
11. Đàm Khai Hoàn. Giáo dục và nâng cao sức khỏe. Nhà xuất bản Y học. 2007.
12. Rella Indah Karunia. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia. J Basic Clin Physiol Pharmacol. 2020. 13;30(6). https://doi.org/10.1515/jbcpp-2019-0299
13. Shanmugalingam R., Mengesha, Z., Notaras, S., Liamputtong, P., Fulcher, I., Lee, G., et al. Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: A mixed method analysis. PLoS One. 2020. 15(2), e0229622.
https://doi.org/10.1371/journal.pone.0229622.